TIGIT expression is elevated in CD8+ T cells of several malignant tumors, and a high TIGIT/DNAM1 ratio in Treg correlates with poor prognosis after blockade of the PD-1 and/or CTLA-4 pathways. This evidence concerns the gene CD8A and cancer.